Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population
CarPoS
1 other identifier
observational
100
1 country
2
Brief Summary
Systemic transthyretin amyloidosis is an aging-related disorder. It is usually associated with cardiac disease but also extends to other organs. Recent studies found that idiopathic carpal tunnel syndrome patients may have amyloid deposition in tenosynovial tissue. The main aims of this project are the characterization of the association between idiopathic carpal tunnel syndrome and transthyretin amyloidosis and its evaluation as a predictive factor of cardiac amyloidosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2020
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 3, 2022
CompletedFirst Posted
Study publicly available on registry
June 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedOctober 19, 2023
June 1, 2023
4 years
June 3, 2022
October 18, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Frequency of transthyretin amyloidosis in synovial in patients with ≥60 years old
Number of patients with transthyretin amyloidosis in synovial in relation to total number of patients submitted to hand surgery
24 months
Secondary Outcomes (2)
Association between synovial transthyretin amyloidosis with carpal tunnel syndrome
24 months
Association between idiopathic carpal tunnel syndrome with cardiac transthyretin amyloidosis
24 months
Study Arms (2)
Group 1
Patients aged ≥ 60 years old with symptomatic carpal tunnel syndrome submitted to surgery
Group 2
Patients aged ≥ 60 years old without symptomatic carpal tunnel syndrome submitted to hand surgery
Interventions
Congo red and Immunohistochemical analysis and/or Mass spectrometry analysis
Eligibility Criteria
Patients with ≥60 years old submitted to hand surgery
You may qualify if:
- Patients aged ≥ 60 years old with symptomatic idiopathic carpal tunnel syndrome or other hand surgery indications.
You may not qualify if:
- Diabetes mellitus, hypothyroidism, hemodialysis, rheumatoid arthritis, and other inflammatory arthropathies, multiple myeloma, gout, chondrocalcinosis, Colles fracture, space-occupying lesions, and infectious synovitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidade do Portolead
- Centro Hospitalar De São João, E.P.E.collaborator
- Centro de Investigação em Tecnologias e Serviços de Saúdecollaborator
- Rede de Investigação em Saúdecollaborator
Study Sites (2)
Centro Hospitalar Universitário São João
Porto, 4200-319, Portugal
Faculty of Medicine (FMUP)
Porto, 4200-319, Portugal
Biospecimen
biopsy and peripheral blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elisabete Martins, MD, PhD
Universidade do Porto
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2022
First Posted
June 8, 2022
Study Start
June 1, 2020
Primary Completion
June 1, 2024
Study Completion
June 1, 2025
Last Updated
October 19, 2023
Record last verified: 2023-06